Prevention of Unexplained Recurrent Abortion by Enoxaparine

NCT00740545 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

258

Enrollment

OTHER

Sponsor class

Stopped Stopped for futility

Conditions

Alive and Viable Births

Interventions

DRUG: enoxaparine 40 mg daily
DRUG: placebo

Sponsor

University Hospital, Brest